Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective.
作者信息
Rees Chris A, Brousseau David C, Ahmad Fahd A, Bennett Jonathan, Bhatt Seema, Bogie Amanda, Brown Kathleen M, Casper T Charles, Chapman Laura L, Chumpitazi Corrie E, Cohen Daniel M, Dampier Carlton, Ellison Angela M, Grasemann Hartmut, Hickey Robert W, Hsu Lewis L, Lane Peter A, Bakshi Nitya, Leibovich Sara, Patil Prabhumallikarjun, Powell Elizabeth C, Richards Rachel, Sarnaik Syana, Weiner Debra L, Morris Claudia R
机构信息
Division of Pediatric Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
出版信息
Am J Hematol. 2022 Nov;97(11):E412-E415. doi: 10.1002/ajh.26696. Epub 2022 Sep 5.
Abstract
摘要
相似文献
1
Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective.
Am J Hematol. 2022 Nov;97(11):E412-E415. doi: 10.1002/ajh.26696. Epub 2022 Sep 5.
2
An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
J Emerg Nurs. 2021 Jan;47(1):40-49.e1. doi: 10.1016/j.jen.2020.06.001. Epub 2020 Aug 18.
3
A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease.
J Holist Nurs. 1992 Mar;10(1):62-75. doi: 10.1177/089801019201000107.
4
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24.
5
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
JAMA. 2021 Apr 20;325(15):1513-1523. doi: 10.1001/jama.2021.3414.
6
Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
Contemp Clin Trials. 2021 Feb;101:106252. doi: 10.1016/j.cct.2020.106252. Epub 2020 Dec 28.
7
Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
Ann Hematol. 2011 Feb;90(2):145-50. doi: 10.1007/s00277-010-1048-4. Epub 2010 Aug 17.
8
Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
JMIR Res Protoc. 2021 Apr 16;10(4):e24818. doi: 10.2196/24818.
9
Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.
Pain. 2003 Mar;102(1-2):187-93. doi: 10.1016/s0304-3959(02)00374-3.
10
Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia.
Clin Trials. 2017 Dec;14(6):563-571. doi: 10.1177/1740774517723307. Epub 2017 Jul 26.
引用本文的文献
1
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
Trials. 2023 Aug 17;24(1):538. doi: 10.1186/s13063-023-07538-z.
2
Management of fever and acute painful crises in children with sickle cell disease in emergency departments: a tertiary hospital experience.
Front Pediatr. 2023 Jun 12;11:1195040. doi: 10.3389/fped.2023.1195040. eCollection 2023.
3
Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective.
Am J Hematol. 2023 Apr;98(4):620-627. doi: 10.1002/ajh.26837. Epub 2023 Feb 6.
4
Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?
Expert Rev Hematol. 2022 Oct;15(10):887-891. doi: 10.1080/17474086.2022.2131523. Epub 2022 Oct 11.
本文引用的文献
1
Racial and Language Disparities in Pediatric Emergency Department Triage.
Pediatr Emerg Care. 2022 Feb 1;38(2):e556-e562. doi: 10.1097/PEC.0000000000002439.
2
A Multiyear Cross-sectional Study of Guideline Adherence for the Timeliness of Opioid Administration in Children With Sickle Cell Pain Crisis.
Ann Emerg Med. 2020 Sep;76(3S):S6-S11. doi: 10.1016/j.annemergmed.2020.08.006.
3
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
Am J Hematol. 2019 Jun;94(6):689-696. doi: 10.1002/ajh.25471. Epub 2019 Apr 29.
4
Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
Pediatrics. 2015 Oct;136(4):e1016-25. doi: 10.1542/peds.2014-3470. Epub 2015 Sep 21.
5
Acute care utilization and rehospitalizations for sickle cell disease.
JAMA. 2010 Apr 7;303(13):1288-94. doi: 10.1001/jama.2010.378.
6
Management of sickle cell pain crisis in the emergency department at teaching hospitals.
J Emerg Med. 1999 Jul-Aug;17(4):625-30. doi: 10.1016/s0736-4679(99)00050-5.
Zotero 插件